RecruitingPhase 3NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Dallas, TX · Plano, TX · +41 more sites
4 recruiting multiple sclerosis studies with a site in Plano, TX.
Sponsor: Novartis Pharmaceuticals
Dallas, TX · Plano, TX · +41 more sites
Sponsor: Sanofi
El Paso, TX · Plano, TX · +31 more sites
Sponsor: Novartis Pharmaceuticals
Austin, TX · Dallas, TX · Fort Worth, TX · +41 more sites
Sponsor: ModernaTX, Inc.
Dallas, TX · El Paso, TX · Plano, TX · +5 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.